Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY

Mid Cap | Pharmaceuticals & Drugs

1234.60

-10.90 (-0.88%)

< Home < Back

Dr. Reddys Laboratories informs about press release

Date: 28-10-2020

Dr. Reddys Laboratories has informed that it has enclosed a Press Release in term of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 on 28 October 2020 titled ‘Dr. Reddy's Laboratories announces appointment of new Chief Financial Officer’.

The above information is a part of company’s filings submitted to BSE.